登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>Spike protein >RAS-A020

SARS-CoV-2 Spike Protein Titer Assay Kit

For research use only.

IDComponentsSize
RAS020-C01Pre-coated with Anti-SARS-CoV-2 Spike Protein Antibody Microplate 1 plate
RAS020-C02SARS-CoV-2 Spike Protein10 μg
RAS020-C03Biotin-Anti-SARS-CoV-2 Spike Protein Antibody10 μg
RAS020-C04Streptavidin-HRP10 μg
RAS020-C0510xWashing Buffer 50 mL
RAS020-C06Dilution Buffer50 mL
RAS020-C07Substrate Solution12 mL
RAS020-C08Stop Solution7 mL

背景(Background)

The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

应用说明(Application)

This kit is developed for detecting SARS-CoV-2 Spike Protein in vaccine samples, which can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and quality control, and realize accurate quantification of vaccine antigen contents for COVID-19 vaccines of all technological platforms, multivalent vaccines, and VOC-specific boosters.

It is for research use only.

重构方法(Reconstitution)

Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

存储 & 运输(Storage & Shipping)

1. Unopened kit should be stored at 2℃-8℃ upon receiving.

2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

Shipping Statement

原理(Assay Principles)

This assay kit employs a standard sandwich-ELISA format, providing a rapid detection of SARS-CoV-2 Spike Protein. The kit consists of microplate pre-coated with Anti-SARS-CoV-2 Spike protein Antibody, an SARS-CoV-2 Spike Protein as Control, an biotin-Anti-SARS-CoV-2 Spike protein Antibody, HRP-Streptavidin and buffers.

Your experiment will include 6 simple steps:

a) All reagents were returned to room temperature(20°C-25°C) before use.

b) Add your sample to the plate, take the SARS-CoV-2 Spike protein as Control sample. The samples and Control sample are diluted by Dilution Buffer.

c) Add a diluted Secondary antibody biotin-Anti-SARS-CoV-2 Spike protein Antibody to the plate. The Secondary antibody is diluted by Dilution Buffer.

d) Add a diluted Streptavidin-HRP to the plate.

e) Wash the plate and add TMB or other colorimetric HRP substrate.

f) Stop the substrate reaction by add diluted acid. Absorbance (OD) is calculated as the absorbance at 450 nm minus the absorbance at 630 nm to remove background prior to statistical analysis. The OD Value reflects the amount of protein bound.

 

典型数据-Typical Data Please refer to DS document for The assay protocol.

Spike protein TYPICAL DATA

This assay kit employs a standard sandwich-ELISA format, providing a rapid detection of SARS-CoV-2 Spike protein. The kit consists of pre-coated Anti-SARS-CoV-2 Spike Protein Antibody Microplate, SARS-CoV-2 Spike protein as Control, biotin-Anti-SARS-CoV-2 Spike protein antibody and HRP-Streptavidin. Detection is performed using HRP-Streptavidin with sensitivity of 200 pg/mL.

Spike protein TYPICAL DATA

SARS-CoV-2 Spike Protein Titer Assay Kit (Cat.No.RAS-A020) can potently to detect the all SARS-CoV-2 Variants of Concern (VOCs), including Alpha (Cat.No.SPN-C52H6), Beta (Cat.No.SPN-C52Hk), Gamma (Cat.No.SPN-C52Hg) and Delta (Cat.No.SPN-C52He).

Spike protein TYPICAL DATA

SARS-CoV-2 Spike Protein Titer Assay Kit (Cat.No.RAS-A020) can potently to detect the all SARS-CoV-2 Variants of Concern (VOCs), including Omicron (Cat.No.SPN-C52Hz).

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
Spike protein靶点信息
英文全称:Coronavirus spike glycoprotein
中文全称:冠状病毒刺突糖蛋白
种类:Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
上市药物数量:9详情
临床药物数量:68详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定